Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study

Background and purpose: In advanced ovarian cancer, delayed time to chemotherapy (TTC) has been associated with poorer survival outcomes; evidence is conflicting, however. This study investigated the impact of patient demographic factors on TTC and assessed whether TTC was associated with 5-year ove...

Full description

Bibliographic Details

Published in:	ESMO Real World Data and Digital Oncology
Main Authors:	L. Steventon, S. Nicum, K. Man, D. Dodwell, Z. Wang, A. Patel, B. Pickwell-Smith, L. Wei, P. Chambers
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	cancer ovarian surgery adjuvant chemotherapy treatment equity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949820125000323